This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Anna Petryk
Introduction
Anna Petryk is a notable inventor based in New Haven, CT (US). She has made significant strides in the field of medical treatments, particularly focusing on neurofibromatosis type 1. Her work is characterized by a commitment to improving patient outcomes through innovative methods.
Latest Patents
Anna holds a patent for "Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase." This patent features methods for treating at least one symptom of neurofibromatosis type 1, addressing symptoms of dystrophic scoliosis, and inducing bone healing by administering a soluble alkaline phosphatase (sALP) to patients. This innovative approach highlights her dedication to advancing medical science.
Career Highlights
Anna is currently associated with Alexion Pharmaceuticals, Inc., where she continues to contribute to groundbreaking research and development in the pharmaceutical industry. Her role at the company allows her to apply her expertise in a practical setting, further enhancing her impact on healthcare.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Anna Petryk's contributions to the field of medical innovation are commendable, and her patent reflects her dedication to improving treatments for complex conditions. Her work at Alexion Pharmaceuticals, Inc. positions her as a key player in the advancement of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile